Synchronization of Tumor and Normal Cells from G1 to Multiple Cell Cycles by Lovastatin

Cancer Research

Volumn 51, Issue 13, 1991, Pages 3602-3609

  Keyomarsi, Khandan ^a   Sandoval, Larue ^a   Band, Vimla ^a   Pardee, Arthur B ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MEVALONIC ACID; MEVINOLIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL SYNCHRONIZATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMAL; BLOTTING, NORTHERN; CELL CYCLE; CELLS, CULTURED; CULTURE MEDIA; DNA; GENE EXPRESSION; HAMSTERS; HISTONES; HUMAN; KI-67 ANTIGEN; LOVASTATIN; MICE; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RNA; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0026039147     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Pardee, A. B. GI events and regulations of cell proliferation. Science (Washington DC), 246:603-608, 1989.
2. Pardee, A. B. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA, 71: 1286-1290,1974.
3. Ashihara, T., and Baserga, R. Cell synchronization. Methods Enzymol., 58: 248-262, 1979.
4. Grdina, D. J., Meistrich, M. L., Meyn, R. E., Johnson, T. S., and White, R. A. Cell synchrony techniques. A comparison of methods. In: J. W. Gray and Z. Darzynkiewicz (eds.). Techniques in Cell Cycle Analysis, pp. 367-402. Clifton, NJ: Humana Press, 1987.
5. Zetterberg, A., and Skold, O. The effect of serum starvation or DNA, RNA and protein synthesis during interphase in L-cells. Exp. Cell Res., 57: 114-118, 1969.
6. Medrano, E. E., and Pardee, A. B. Prevalent deficiency in tumor cells of cycloheximide induced cell cycle arrest. Proc. Natl. Acad. Sci. USA, 77: 4123-4126, 1980.
7. Scher, C. D., Stone, M. E., and Stiles, C. D. Platelet-derived growth factor prevents Go growth arrest. Nature (Lond.), 281:390-392, 1979.
8. Alberts, A. W., Chen, J., Kuron, G., Hunt, V., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., Albers-Schonberg, G., Hensens, O., Hirshfield, G., Hoogsteen, K., Liesch, J., and Springer, J. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA, 77: 3957-3961, 1980.
9. Endo, A., Kuroda, M., and Tansawa, K. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B, fungal metabolites having hypocholesterolemic activity. FEBS Lett., 72: 323-326, 1976.
10. Larson, R. A., Chung, J., Scanu, A. M., and Yachnin, S. Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved. Proc. Natl. Acad. Sci. USA, 79:3028-3032, 1982.
11. Habenicht, A. J. R., Glomset, J. A., and Ross, R. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem., 255: 5134-5140,1980.
12. Maltese, W. A., and Sheridan, K. M. Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J. Cell. Physiol., 133:471-481, 1987.
13. Langan, T. J., and Volpe, J. J. Cell cycle-specific requirement for mevalonate, but not for cholesterol, for DNA synthesis in glial primary cultures. J. Neurochem., 49: 513-521, 1987.
14. Doyle, J. W., and Kandutsch, A. A. Requirement for mevalonate in cycling cells: quantitative and temporal aspects. J. Cell. Physiol., 137: 133-140, 1988.
15. Sinensky, M., and Logel, J. Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate. Proc. Natl. Acad. Sci. USA, 82: 3257-3261, 1985.
16. Todaro, G. J., and Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 77: 299-313, 1963.
17. Holley, R. W., Baldwin, J. H., Kieman, J. A., and Messmer, T. O. Control of growth of benzo(a)pyrene-transformed 3T3 cells. Proc. Natl. Acad. Sci. USA, 73: 3229-3232, 1976.
18. Sager, R., and Kovac, P. E. Genetic analysis of tumorigenesis: I. Expression of tumor-forming ability in hamster hybrid cell lines. Somat. Cell. Genet., 4: 375-392, 1978.
19. Smith, B. L., and Sager, R. Multistep origin of tumor-forming ability in Chinese hamster embryo fibroblast cells. Cancer Res., 42:389-396, 1982.
20. Band, V., and Sager, R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports longterm growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
21. Band, V., Zajchowski, D., Swisshelm, K., Trask, D., Kulesa, V., Cohen, C., Connolly, J., and Sager, R. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res., 50: 7351-7357, 1990.
22. Snedcor, G. W. Curvilinear regression. In: Statistical Methods, pp. 42-52. Ames, I A: Iowa State College Press, 1956.
23. Harrock, D. L. The H number concept. Beckman Technical Bulletin, 1095-NUC-77-IT, Irvine, CA, 1977.
24. Johnson, G. D., and Nogueira Araujo, G. M. d. C. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods, 43: 349-350, 1981.
25. Chirgwin, J. M., Przbyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry, 7A-5294-5299, 1979.
26. Gudas, J. M., Knight, B. G., and Pardee, A. B. Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis. Proc. Natl. Acad. Sci. USA, 85:4705-4709, 1988.
27. Feinberg, A. P., and Vogelstein, B. A. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 712;6-13, 1983.
28. Battey, J., Moulding, C., Taub, R., Murphy, W., Stewart, T., Potter, H., Lenoir, G., and Leder, P. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell, 34: 779-787, 1983.
29. Plumb, M., Stein, J., and Stein, G. Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. Nucleic Acids Res., 77; 2391-2410, 1983.
30. Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res., 10: 7895-7903, 1982.
31. Murphy, J. S., D'Alisa, R., Gershey, E. L., and Landsberger, F. R. Kinetics of desynchronization and distribution of generation times in synchronized cell populations. Proc. Natl. Acad. Sci. USA, 75: 4404-4407, 1978.
32. Engelberg, J. A method of measuring the degree of synchronization of cell populations. Exp. Cell Res., 23: 218-227, 1961.
33. Gerdes, J., Schwab, U., Lemke, H., and Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer, 31: 13-20, 1983.
34. Gerdes, J., Lemke, H., Baisch, H., Wacker, H-H., Schwab, U., and Stein, H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen deflned by the monoclonal antibody Ki-67. J. Immunol., 133: 1710-1715, 1984.
35. Terasima, T., and Tolmach, L. J. Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells. Exp. Cell Res., 30: 344-362, 1963.
36. Mitchell, B. F., and Tupper, J. T. Synchronization of mouse 3T3 and SV40 3T3 cells by way of centrifugal elutriation. Exp. Cell Res., 106: 351-355, 1977.
37. Dean, P. N., Gray, J. W., and Dolbeare, P. A. The analysis and interpretation of DNA distributions measured by flow cytometry. Cytometry, 3: 188-195, 1982.
38. Tobey, T. A., and Ley, K. D. Regulation of initiation of DNA synthesis in Chinese hamster cells. I. Production of a stable, reversible Gi-arrested populations in suspension culture. J. Cell Biol. 46: 151-157, 1970.
39. Studzinski, G. P., and Lambert, W. C. Thymidine as a synchronizing agent I. Nucleic acid and protein formation in with excess thymidine. J. Cell. Physiol., 73: 109-115, 1969.
40. Sen, S., Erba, E., and D'Incalci, M. Synchronisation of cancer cell lines of human origin using methotrexate. Cytometry, 11: 595-602, 1990.
41. Yunis, J. J. High resolution of human chromosomes. Science (Washington DC), 191: 1268-1270, 1976.
42. Mironescu, S., and Ellem, K. A. O. Secondary activities of diverse inhibitors potentiate the response of hamster embryo cultures to a mitotic stimulus. J. Cell. Physiol., 90: 281-294, 1977.
43. Tobey, R. A., Valdez, J. G., and Crissman, H. A. Synchronization of human diploid fibroblasts at multiple stages of the cell cycle. Exp. Cell Res., 179: 400-416, 1988.
44. Matherly, L. H., Schuetz, J. D., Westin, E., and Goldman, I. D. A method for the synchronization of cultured cells with aphidicolin: application to the large-scale synchronization of LI210 cells and the study of the cell cycle regulation of thymidylate synthase and dihydrofolate reductase. Anal. Biochem., 182: 338-345, 1989.
45. Goldstein, J. L., and Brown, M. S. Regulation of the mevalonate pathway. Nature (Lond.), 343:425-430, 1990.
46. Kaneko, I., Hazama-Shimada, Y. and Endo, A. Inhibitory effects on lipid metabolism of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Eur. J. Biochem., 87:313-321,1978.
47. Faust, J. R., Brown, M. S., and Goldstein, J. L. Synthesis of isopentenyl tRNA from mevalonate in cultured human fibroblasts. J. Biol. Chem., 255: 6546-6548,1980.
48. Maltese, W. A. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J., 4: 3319-3328,1990.
49. Quesney-Huneeus, V., Wiley, M. H., and Siperstein, M. D. Essential role for mevalonate synthesis in DNA replication. Proc. Natl. Acad. Sci. USA, 76: 5056-5060, 1979.
50. Perkins, J. L., Ledin, J. F., and Stubbs, J. D. Linkage of the isoprenoid biosynthesis pathway with induction of DNA synthesis in mouse lymphocytes. Effects of compactin on mitogen induced lymphocytes in serum-free medium. Biochim. Biophys. Acta 711:83-89, 1982.
51. Witte, L. D., Fairbanks, K. P., Barbu, V., and Goodman, D. S. Studies on cell proliferation and mevalonic acid metabolism in cultured human fibroblasts. Ann. NY Acad. Sci., 454: 261-269, 1985.
52. Casey, P. J., Solski, P. A., Der, C. J., and Buss, J. E. p21ras is modified by a fanesyl isoprenoid. Proc. Natl. Acad. Sci. USA, 86:8323-8327,1989.
53. Hancock, J. F., Magee, A. I., Childs, J. E., and Marshall, C. J. All ras proteins are polyisoprenylated but some are palmitoylated. Cell, 57: 1167-1177, 1989.
54. DeClue, J. E., Vass, W. C., Papageorge, A. G., Lowy, D. R., and Willumsen, B. M. Inhibition of cell growth by Lovastatin is independent of ras function. Cancer Res., 51:712-717, 1991.